Page last updated: 2024-08-05 10:44:46
n-alkanal
An aliphatic aldehyde obtained by formal oxygenation of one of the terminal methyl groups of any straight-chain alkane.
ChEBI ID: 12834
Members (6)
Member | Definition | Role |
---|---|---|
caprylic aldehyde | A saturated fatty aldehyde formally arising from reduction of the carboxy group of caprylic acid (octanoic acid). | octanal |
decanaldehyde | A saturated fatty aldehyde formally arising from reduction of the carboxy group of capric acid (decanoic acid). | decanal |
heptanal | An n-alkanal resulting from the oxidation of the alcoholic hydroxy group of heptan-1-ol to the corresponding aldehyde. An endogenous aldehyde coming from membrane lipid oxidation, it is found in the blood of lung cancer patients and has been regarded as a potential biomarker of lung cancer. | heptanal |
n-hexanal | A saturated fatty aldehyde that is hexane in which one of the terminal methyl group has been mono-oxygenated to form the corresponding aldehyde. | hexanal |
nonanal | A saturated fatty aldehyde formally arising from reduction of the carboxy group of nonanoic acid. Metabolite observed in cancer metabolism. | nonanal |
undecanal | A saturated fatty aldehyde formally arising from reduction of the carboxylic acid group of undecanoic acid. It is a component of essential oils from citrus plants like Citrus reticulata. | undecanal |
Research
Studies (620)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 27 (4.35) | 18.7374 |
1990's | 61 (9.84) | 18.2507 |
2000's | 179 (28.87) | 29.6817 |
2010's | 251 (40.48) | 24.3611 |
2020's | 102 (16.45) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1 (0.13%) | 5.53% |
Reviews | 5 (0.65%) | 6.00% |
Case Studies | 3 (0.39%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 766 (98.84%) | 84.16% |